Insider Purchases: Inside the Buy
Tag: InsiderBuying
MaxCyte (MXCT) — Insiders Load Up While Cash Burns
MaxCyte insiders are shopping biotech shares like it’s Black Friday 🛒💉. With revenue slipping, cash burning, but institutions holding, is MXCT a comeback spark ⚡ or a treadmill burn-out 🔥?
Key Insider Buys Shares of Warner Bros Discovery (WBD). That’s All, Folks!
Director Anton Levy — a seasoned tech investor — just loaded up on Warner Bros Discovery stock (WBD). With subs rising and studios shining, could this be the start of a blockbuster comeback… or just another Hollywood flop? 🎥
Insiders Are Buying Shares of Applied Optoelectronics. Should You?
Applied Optoelectronics (AAOI) insiders—including the CEO—are buying big while revenue growth accelerates and losses shrink. Institutions already own two-thirds of the stock. But with dilution risk, short sellers circling, and heavy competition, is AAOI a comeback kid—or just another speculative fiber bet?
Financials Paint a Dire Story… But Tronox’s CEO and Insiders See Light in the TiO₂ Pigment
Tronox isn’t just about titanium dioxide anymore—it’s about insider confidence, global reach, and whether this chemical giant’s bright white future is worth your green 💵. From insider purchases to institutional moves, here’s why investors might want to watch TROX closely.
International Flavors & Fragrances Inc. (IFF): Insiders Buy Big, CEO Doubles Down, and the Scent of Value Is in the Air
Insiders at International Flavors & Fragrances (IFF) are loading up on shares—CEO included. With a $500M buyback, big-name institutional holders, and portfolio reshaping, the stock could be brewing a comeback. But is it perfume… or still a whiff of trouble?
How Many Insider Buys Will It Take for The Bull in Enphase Energy to Re-energize?
After a brutal drop, Enphase Energy’s CEO is buying big. Institutions are all in. Margins hold strong. Could this be the spark the solar bull needs?
COO Goes Shopping: Is Molina Healthcare (MOH) a Healthy Buy or Just a Check-Up?
When the COO of Molina Healthcare spends $1.56M on stock, investors notice. With Wall Street titans on board and shares at major support, is this a healthy buy — or a risky patient?
Proto Labs (PRLB): The CEO Bought Shares. Should You?
The CEO of Proto Labs just invested in his own company — but it’s not just him. Wall Street giants are in, revenue’s at record levels, and PRLB might be building toward a breakout. Should you 3D-print it into your portfolio?
MSCI Keeps Winning — and the CEO Keeps Buying In
MSCI delivers world-class data tools for investors—and its CEO just bought in big. With soaring revenue, recurring subscriptions, and loyal institutions, is this still a buy? Or has the stock outpaced its fundamentals?
EPD: Enterprise Products Partners Is Boring—But It Pays to Be Boring
Enterprise Products Partners (EPD) might not make headlines, but it makes money. With insiders buying big, a solid 7% dividend, and decades of steady growth, this is one midstream stock that flows cash — not drama.